JP3057887B2 - Novel maleimide derivative and fluorescent labeling method of compound having thiol group using the same - Google Patents

Novel maleimide derivative and fluorescent labeling method of compound having thiol group using the same

Info

Publication number
JP3057887B2
JP3057887B2 JP4081564A JP8156492A JP3057887B2 JP 3057887 B2 JP3057887 B2 JP 3057887B2 JP 4081564 A JP4081564 A JP 4081564A JP 8156492 A JP8156492 A JP 8156492A JP 3057887 B2 JP3057887 B2 JP 3057887B2
Authority
JP
Japan
Prior art keywords
compound
thiol group
fluorescent labeling
reaction
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP4081564A
Other languages
Japanese (ja)
Other versions
JPH06122679A (en
Inventor
英雄 加藤
直之 山本
慎二 里村
巧 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Wako Pure Chemical Corp
Original Assignee
Wako Pure Chemical Industries Ltd
Fujifilm Wako Pure Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wako Pure Chemical Industries Ltd, Fujifilm Wako Pure Chemical Corp filed Critical Wako Pure Chemical Industries Ltd
Priority to JP4081564A priority Critical patent/JP3057887B2/en
Publication of JPH06122679A publication Critical patent/JPH06122679A/en
Application granted granted Critical
Publication of JP3057887B2 publication Critical patent/JP3057887B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の利用分野】本発明は、チオール基を有する化合
物の水溶性蛍光標識化試薬として有用な新規なマレイミ
ド誘導体と、該化合物を水溶性蛍光標識化試薬として用
いたチオール基を有する化合物の蛍光標識化方法に関す
る。
The present invention relates to a novel maleimide derivative useful as a water-soluble fluorescent labeling reagent for a compound having a thiol group, and the fluorescence of a compound having a thiol group using the compound as a water-soluble fluorescent labeling reagent. It relates to a labeling method.

【0002】[0002]

【発明の背景】測定対象物質を蛍光物質で標識した後、
その蛍光を利用して該物質を測定する方法は、試料中に
ナノモル〜ピコモル程度しか含まれていない微量物質の
測定方法として広く利用されている。
BACKGROUND OF THE INVENTION After a substance to be measured is labeled with a fluorescent substance,
The method of measuring the substance using the fluorescence is widely used as a method of measuring a trace substance containing only about nanomoles to picomoles in a sample.

【0003】しかしながら、従来から用いられている測
定対象物質を蛍光標識するための試薬、即ちフルオレッ
センイソチオシアネート(FITC)、エオシン、クマリン
イソチオシアネート等の蛍光標識化試薬は、それ自体の
水溶性が低いため種々の問題点を有していた。即ち、例
えば水溶液中に含まれている微量物質を蛍光標識化する
際には、上記した如き蛍光標識化試薬は一旦極性有機溶
媒に溶解して用いなければならないため、蛍光標識化操
作が煩雑であることや、上記した如き蛍光標識化試薬を
用いて調製された蛍光標識化物質はそれ自体の水溶性が
低下するため、例えば上記蛍光標識化試薬を用いて調製
された蛍光標識化抗体を利用して他の物質の検出を行う
場合に必要濃度の水溶液を調製することができない場合
があること、等である。
However, conventionally used reagents for fluorescently labeling a substance to be measured, ie, fluorescently labeled reagents such as fluorescein isothiocyanate (FITC), eosin and coumarin isothiocyanate, have a water solubility of their own. Due to its low cost, it had various problems. That is, for example, when fluorescently labeling a trace substance contained in an aqueous solution, the fluorescent labeling reagent as described above must be once dissolved and used in a polar organic solvent, so that the fluorescent labeling operation is complicated. In addition, since the fluorescence-labeled substance prepared using the fluorescent-labeling reagent as described above has reduced water solubility of itself, for example, a fluorescent-labeled antibody prepared using the fluorescent-labeling reagent is used. In some cases, it may not be possible to prepare an aqueous solution having a required concentration when another substance is detected.

【0004】これらの問題点を解決する目的で、例えば
スルホ基、カルボキシル基等の水溶性基を導入した、ダ
ンシルクロライド、ルシファーイエロー、o-フタルアル
デヒド等の水溶性蛍光標識化試薬が開発された。しかし
ながら、これらを用いて調製された蛍光標識化物質は、
水溶性という面では改善されたものの、それ自体の保存
安定性が悪いため、調製後の保存ができないという問題
点を有していた。
For the purpose of solving these problems, a water-soluble fluorescent labeling reagent such as dansyl chloride, lucifer yellow, o-phthalaldehyde and the like, into which a water-soluble group such as a sulfo group or a carboxyl group has been introduced, has been developed. . However, the fluorescent labeling substances prepared using these are:
Although it was improved in water solubility, it had a problem that it could not be stored after preparation because of its poor storage stability.

【0005】一方、2-アミノピリジン、3-アミノピリジ
ン等のアミノピリジンは、それ自体水溶性で且つ非常に
安定な蛍光物質であり、該アミノピリジンにより標識さ
れた物質も保存安定性に優れ、且つ、標識対象物質が水
溶性のものの場合には水溶性がそのまま維持されるた
め、糖質等への蛍光標識物質として近時、広く利用され
ている化合物である(Biochemical and Biophysical Re
search Communicationsvol.85,257頁,1978等)。
On the other hand, aminopyridines such as 2-aminopyridine and 3-aminopyridine are water-soluble and very stable fluorescent substances themselves, and substances labeled with the aminopyridine also have excellent storage stability. In addition, when the labeling substance is a water-soluble substance, the water-soluble property is maintained as it is, and therefore, it is a compound widely used recently as a fluorescent labeling substance for carbohydrates (Biochemical and Biophysical Reagent).
search Communications vol. 85, p. 257, 1978).

【0006】しかしながら、アミノピリジンそのもの
を、例えば抗体、酵素、ホルモン、各種因子類(例えば
成長因子、増殖因子等)、ハプテン等の生理活性物質の
標識物質として用いるには問題があった。即ち、アミノ
ピリジンを用いた蛍光標識化方法としては、標識対象物
質のアルデヒド基にシッフ塩基を介して結合させる方法
が一般的であるが、該方法を利用してアミノピリジンを
標識対象物質に高収率で且つ定量的に結合させるために
は、標識操作を非水条件下で、且つ90℃前後の高温で行
なわなければならないため(Agri. Biol. Chem.,vol.5
4,2169頁,1990)、標識された抗体等の生理活性物質の
例えば抗体活性、酵素活性、生理活性等が失活する場合
が多いという問題がそれである。
However, there has been a problem in using aminopyridine itself as a labeling substance for physiologically active substances such as antibodies, enzymes, hormones, various factors (eg, growth factors, growth factors, etc.), haptens and the like. That is, as a fluorescent labeling method using aminopyridine, a method of binding to an aldehyde group of a labeling target substance via a Schiff base is generally used. In order to perform binding in a yield and quantitatively, the labeling operation must be performed under non-aqueous conditions and at a high temperature of about 90 ° C. (Agri. Biol. Chem., Vol. 5).
4,2169, 1990), which is a problem in that, for example, antibody activity, enzyme activity, biological activity, etc. of a labeled physiologically active substance such as an antibody are often inactivated.

【0007】そのため、ピリジルアミノ基を、穏和な条
件下で抗体、酵素、ホルモン、各種因子類、ハプテン等
の生理活性物質に導入し得る標識化試薬の開発が望まれ
ていた。
[0007] Therefore, development of a labeling reagent capable of introducing a pyridylamino group into a physiologically active substance such as an antibody, an enzyme, a hormone, various factors, or a hapten under mild conditions has been desired.

【0008】[0008]

【発明の目的】本発明は、上記した如き状況に鑑みなさ
れたもので、ピリジルアミノ基を、水又は極性有機溶
媒、或はこれらの混合溶媒中に於いて穏和な条件下でチ
オール基を有する化合物に容易に導入し得る標識化試薬
と、該標識化試薬を用いたチオール基を有する化合物の
蛍光標識化方法を提供することをその目的とする。
SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned circumstances, and is intended to provide a compound having a thiol group under mild conditions in water or a polar organic solvent or a mixture thereof in water or a polar organic solvent. It is an object of the present invention to provide a labeling reagent that can be easily introduced into DNA, and a method for fluorescently labeling a compound having a thiol group using the labeling reagent.

【0009】[0009]

【発明の構成】本発明は、下記一般式(1)The present invention provides a compound represented by the following general formula (1):

【化3】 (式中、R1は2-ピリジルアミノ基又は3-ピリジルアミ
ノ基を表わし、nは1〜4の整数を表わす。)で示され
る化合物又はその塩、及び上記一般式(1)で表わされる
化合物又はその塩と、チオール基を有する化合物とを水
又は極性有機溶媒、或はこれらの混合溶媒中で反応させ
ることを特徴とする、チオール基を有する化合物の蛍光
標識化方法の発明である。
Embedded image (Wherein R 1 represents a 2-pyridylamino group or a 3-pyridylamino group, and n represents an integer of 1 to 4) or a salt thereof, and a compound represented by the above general formula (1) or a compound thereof. It is an invention of a method for fluorescently labeling a compound having a thiol group, comprising reacting a salt with a compound having a thiol group in water or a polar organic solvent, or a mixed solvent thereof.

【0010】本発明の一般式(1)で示される化合物は、
例えば以下の如くして容易に合成し得る。即ち、先ず、
例えば2-クロロピリジン,2-ブロモピリジン,3-クロロ
ピリジン,3-ブロモピリジン等の2-又は3-ハロピリジン
と、該2-又は3-ハロピリジン1モルに対して通常2〜30
モル、好ましくは10〜20モルのアルキレンジアミン(例
えばエチレンジアミン,1,3-プロパンジアミン,1,4-ブ
タンジアミン等)とを、80〜120℃で6〜48時間撹拌下
に反応させる。反応後は、反応液を減圧濃縮し、目的物
をクロロホルム、ジクロロメタン等で抽出し、溶媒留去
後、残渣を適当な溶媒(例えばベンゼンと石油エーテル
の混合溶媒等)から再結晶して、例えば2-(2-アミノエ
チル)アミノピリジン等のアミノアルキルアミノピリジ
ンを得る。次いで、これと、アミノアルキルアミノピリ
ジン1モルに対して通常1〜5モル、好ましくは1〜3
モルのN-アルコキシカルボニルマレイミド(例えばN-メ
トキシカルボニルマレイミド,N-エトキシカルボミルマ
レイミド等)とを、弱アルカリ水溶液(例えば炭酸水素
ナトリウム水溶液,炭酸水素カリウム水溶液等)中、0
〜30℃で2〜6時間撹拌下に反応させる。反応後、沈殿
を瀘取、水洗した後、要すれば、反応を完結させる目的
で、これを例えばジオキサン,テトラヒドロフラン等の
溶媒に懸濁し、0〜10℃に冷却下アミノアルキルアミノ
ピリジン1モルに対して0.5〜2モルの例えばトリエチ
ルアミン,N-メチルモルホリン,N,N-ジイソプロピルエ
チルアミン等の塩基を加えて、同温度で1〜2時間撹
拌、反応させ、次いで10〜30℃で更に2〜4時間撹拌下
に反応させる。反応後、溶媒を留去し、残渣から目的物
を例えばクロロホルム,ジクロロメタン等の溶媒で抽出
する。抽出液から溶媒を留去し、残渣を例えばジエチル
エーテル,石油エーテル等の溶媒で再結晶する等により
精製すれば、一般式(1)で示される本発明化合物が得ら
れる。これを更に例えば塩酸,硫酸等の鉱酸や例えば酢
酸等の有機酸と反応させれば、一般式(1)で示される化
合物の鉱酸塩や有機酸塩等が得られる。
The compound represented by the general formula (1) of the present invention is
For example, it can be easily synthesized as follows. That is, first,
For example, 2- or 3-halopyridine such as 2-chloropyridine, 2-bromopyridine, 3-chloropyridine, or 3-bromopyridine, and usually 2 to 30 moles per mole of the 2- or 3-halopyridine.
A mole, preferably 10 to 20 moles of an alkylenediamine (eg, ethylenediamine, 1,3-propanediamine, 1,4-butanediamine, etc.) is reacted with stirring at 80 to 120 ° C. for 6 to 48 hours. After the reaction, the reaction solution is concentrated under reduced pressure, the target substance is extracted with chloroform, dichloromethane, etc., and after the solvent is distilled off, the residue is recrystallized from an appropriate solvent (for example, a mixed solvent of benzene and petroleum ether) to give, for example, An aminoalkylaminopyridine such as 2- (2-aminoethyl) aminopyridine is obtained. Next, this is usually combined with 1 to 5 mol, preferably 1 to 3 mol, per mol of aminoalkylaminopyridine.
One mole of N-alkoxycarbonylmaleimide (eg, N-methoxycarbonylmaleimide, N-ethoxycarbomylmaleimide, etc.) is added to a weak alkaline aqueous solution (eg, an aqueous solution of sodium hydrogencarbonate, an aqueous solution of potassium hydrogencarbonate, etc.).
The reaction is carried out with stirring at 3030 ° C. for 2 to 6 hours. After the reaction, the precipitate is collected by filtration, washed with water, and if necessary, suspended in a solvent such as dioxane or tetrahydrofuran for the purpose of completing the reaction, and cooled to 0 to 10 ° C to 1 mol of aminoalkylaminopyridine under cooling. Then, 0.5 to 2 mol of a base such as triethylamine, N-methylmorpholine, N, N-diisopropylethylamine or the like is added, and the mixture is stirred and reacted at the same temperature for 1 to 2 hours. The reaction is carried out with stirring for hours. After the reaction, the solvent is distilled off, and the target substance is extracted from the residue with a solvent such as chloroform or dichloromethane. By evaporating the solvent from the extract and purifying the residue by recrystallization with a solvent such as diethyl ether or petroleum ether, the compound of the present invention represented by the general formula (1) is obtained. When this is further reacted with a mineral acid such as hydrochloric acid or sulfuric acid or an organic acid such as acetic acid, a mineral acid salt or an organic acid salt of the compound represented by the general formula (1) is obtained.

【0011】尚、上記の反応に於いてマレイミド化試薬
として用いたN-アルコキシカルボニルマレイミドは、ケ
ラーらの方法(Helvetica Chimica Acta,vol.58,531,19
75)に準じて合成したものを用いれば足りる。
The N-alkoxycarbonylmaleimide used as the maleimidating reagent in the above reaction was prepared according to the method of Keller et al. (Helvetica Chimica Acta, vol. 58, 531, 19).
It is sufficient to use one synthesized according to 75).

【0012】本発明化合物を蛍光標識化試薬として用い
た本発明の蛍光標識化方法は、例えばチオール基を有す
る化合物と、該化合物のチオール基1当量に対して、通
常1〜10当量、好ましくは1〜5当量、より好ましくは
2〜4当量の本発明化合物とを、水、又は例えばメタノ
ール,エタノール等のアルコール類、アセトン、アセト
ニトリル、ジメチルホルムアミド等の極性有機溶媒、或
はこれらの極性有機溶媒と水との混合溶媒(以下、これ
らを総称して「水溶媒等」と略記する。)中、室温乃至
若干加温下に反応させることにより容易に実施し得る。
The fluorescent labeling method of the present invention using the compound of the present invention as a fluorescent labeling reagent can be carried out, for example, by adding 1 to 10 equivalents, preferably 1 to 10 equivalents of a compound having a thiol group to 1 equivalent of the thiol group of the compound. 1 to 5 equivalents, more preferably 2 to 4 equivalents of the compound of the present invention is added to water or an alcohol such as methanol or ethanol, a polar organic solvent such as acetone, acetonitrile or dimethylformamide, or a polar organic solvent thereof. The reaction can be easily carried out by reacting the mixture in a mixed solvent of water and water (hereinafter collectively referred to as “aqueous solvent etc.”) at room temperature to slightly heated.

【0013】尚、上記反応を実施する際の反応液のpH
としては、チオール基を有する化合物の安定性に影響が
ない範囲であれば特に限定されないが、本発明化合物の
反応性を勘案すると、中性〜弱アルカリ性(pH6〜8
程度)が望ましい。また、上記反応液中には、水溶性蛍
光標識化試薬としての本発明化合物とチオール基との反
応を阻害しないものであれば、例えばリン酸塩,重炭酸
塩等のチオール基を有さない緩衝剤、防腐剤、界面活性
剤、安定化剤等が共存していてもよい。
[0013] The pH of the reaction solution at the time of carrying out the above reaction is
Is not particularly limited as long as it does not affect the stability of the compound having a thiol group. However, considering the reactivity of the compound of the present invention, neutral to slightly alkaline (pH 6 to 8)
Degree) is desirable. In addition, the reaction solution does not have a thiol group such as a phosphate or a bicarbonate as long as it does not inhibit the reaction between the compound of the present invention as a water-soluble fluorescent labeling reagent and a thiol group. A buffer, a preservative, a surfactant, a stabilizer and the like may be present together.

【0014】本発明の方法は、蛍光標識化操作時に、従
来のダンシルクロライドによる蛍光標識化のように極性
有機溶媒の使用が必須ではないため、例えば抗体、酵
素、ホルモン、各種因子類(例えば成長因子,増殖因子
等)、ハプテン等、有機溶媒により変性されやすい生理
活性物質への標識を容易に行うことができる。
The method of the present invention does not require the use of a polar organic solvent during the fluorescent labeling operation as in the conventional fluorescent labeling with dansyl chloride. Therefore, for example, antibodies, enzymes, hormones, various factors (for example, growth Factors, growth factors, etc.), haptens and the like can be easily labeled with a physiologically active substance which is easily denatured by an organic solvent.

【0015】本発明の方法により蛍光標識化が可能なチ
オール基を有する化合物としては、水溶媒等に1ピコモ
ル以上の濃度で溶解する性質を有する化合物であって、
且つ分子内にチオール基を有する化合物、若しくは分子
内のジスルフィド結合を例えば2-メルカプトエタノー
ル、ジチオスレイトール等の還元剤で還元開裂させるこ
とにより遊離のチオール基を生じさせることのできる化
合物であれば、天然品、合成品を問わず特に限定するこ
となく挙げられる。より具体的には例えばシステイン,
N-アセチルシステイン,シスチン等のアミノ酸、例えば
グルタチオン,インスリンA鎖,インスリンB鎖,カル
シトニン,エンドセリン,オキシトシン,バソプレッシ
ン等のペプチド類、例えばイムノグロブリン,アルブミ
ン,トランスフェリン,黄体形成ホルモン(LH),卵
胞刺激ホルモン(FSH),甲状腺刺激ホルモン(TS
H),ヒト絨毛性ゴナドトロピン(hCG)等の糖蛋白
質(又は蛋白質)、これら糖蛋白質(又は蛋白質)を例
えばトリプシン,キモトリプシン,ペプシン,パパイ
ン,V8プロテアーゼ等のプロテアーゼにより処理して
得られるシステイン(又はシスチン)含有糖ペプチドフ
ラグメント(又はペプチドフラグメント)等が好ましく
挙げられるが、これらに限定されるものではない。
The compound having a thiol group that can be fluorescently labeled by the method of the present invention is a compound having a property of being dissolved in an aqueous solvent or the like at a concentration of 1 picomolar or more,
And a compound having a thiol group in the molecule, or a compound capable of generating a free thiol group by reductive cleavage of a disulfide bond in the molecule with a reducing agent such as 2-mercaptoethanol or dithiothreitol. And natural and synthetic products without particular limitation. More specifically, for example, cysteine,
Amino acids such as N-acetylcysteine and cystine, for example, peptides such as glutathione, insulin A chain, insulin B chain, calcitonin, endothelin, oxytocin, vasopressin, for example, immunoglobulin, albumin, transferrin, luteinizing hormone (LH), follicle stimulation Hormone (FSH), thyroid stimulating hormone (TS)
H), glycoproteins (or proteins) such as human chorionic gonadotropin (hCG), and cysteines (or proteins) obtained by treating these glycoproteins (or proteins) with proteases such as trypsin, chymotrypsin, pepsin, papain, and V8 protease. Preferred examples include, but are not limited to, cystine) -containing glycopeptide fragments (or peptide fragments).

【0016】本発明の方法により蛍光標識化が可能なチ
オール基を有する糖蛋白質(又は糖ペプチド)に於ける
糖鎖としては、その構成糖の種類及び数には特に制限は
ないが、例えばグルコース,マンノース,ガラクトー
ス,フコース,シアル酸,N-アセチルグルコサミン,N-
アセチルガラクトサミン等の糖残基から構成され、その
糖残基の数が1〜10個程度のものが好ましく挙げられ
る。また、該糖鎖の糖残基間の結合の種類にも特に制限
はなく、例えばα1→4,β1→4,α1→6,α2→
3,β1→2,β1→3,α2→6,α1→3,α1→
2,β1→6等何れにてもよい。但し、本発明の方法に
より蛍光標識化した糖蛋白質(糖ペプチド)を糖転移酵
素のアクセプターや糖分解酵素の基質として使用する場
合には、該糖蛋白質(又は糖ペプチド)の糖鎖は、目的
とする糖転移酵素のアクセプターや糖分解酵素の基質と
なり得るものでなければならないことは言うまでもな
い。
The type and number of sugar chains in the glycoprotein (or glycopeptide) having a thiol group which can be fluorescently labeled by the method of the present invention are not particularly limited. , Mannose, galactose, fucose, sialic acid, N-acetylglucosamine, N-
A sugar residue such as acetylgalactosamine, which has about 1 to 10 sugar residues, is preferred. There is no particular limitation on the type of bond between the sugar residues of the sugar chain. For example, α1 → 4, β1 → 4, α1 → 6, α2 →
3, β1 → 2, β1 → 3, α2 → 6, α1 → 3, α1 →
2, β1 → 6, etc. However, when a glycoprotein (glycopeptide) fluorescently labeled by the method of the present invention is used as an acceptor for glycosyltransferase or a substrate for glycolytic enzyme, the sugar chain of the glycoprotein (or glycopeptide) is Needless to say, it must be a substance that can serve as an acceptor for glycosyltransferase or a substrate for glycolytic enzyme.

【0017】本発明の水溶性蛍光標識化試薬は、チオー
ル基と結合することにより初めて強い蛍光を発する性質
を有しているため、未反応の該標識化試薬が共存してい
ても、チオール基の検出への影響が殆ど認められないの
で、検体中の遊離のチオール基の検出や定量、蛋白質や
ペプチド等のプロテアーゼ処理により生ずるフラグメン
ト中のシステイン残基の有無の確認等へ容易に利用が可
能である。
Since the water-soluble fluorescent labeling reagent of the present invention has a property of emitting strong fluorescence only when bound to a thiol group, even if the unreacted labeling reagent coexists, the thiol group can be used. Since it has almost no effect on the detection of cysteine, it can be easily used for detecting and quantifying free thiol groups in samples, and for confirming the presence or absence of cysteine residues in fragments generated by protease treatment of proteins and peptides. It is.

【0018】従来主に用いられてきたダンシルクロライ
ド、フェニルチオヒダントイン(PTH)、ルシファイエロ
ー等の蛍光標識化剤により標識化されたアミノ酸、ペプ
チド、蛋白質、糖ペプチド、糖蛋白質等は保存時の安定
性が悪いため、標準品でさえ用時調製しなければならな
いという問題点を有していた。一方、本発明化合物を用
いて蛍光標識化されたアミノ酸、ペプチド、蛋白質、糖
ペプチド、糖蛋白質等は保存時の安定性が極めて高いの
で、予め調製したものを標準品として適宜使用すること
が可能である。尚、本発明化合物により蛍光標識化され
たアミノ酸、ペプチド、蛋白質、糖ペプチド、糖蛋白質
等の検出感度は数ヒ゜コモルと極めて高感度である。
Amino acids, peptides, proteins, glycopeptides, glycoproteins, and the like, which have been conventionally labeled with fluorescent labeling agents such as dansyl chloride, phenylthiohydantoin (PTH), and lucifer yellow, are stable upon storage. Because of poor properties, even a standard product had to be prepared before use. On the other hand, amino acids, peptides, proteins, glycopeptides, glycoproteins, and the like, which are fluorescently labeled using the compound of the present invention, have extremely high storage stability, and thus, those prepared in advance can be used as appropriate as standard products. It is. The detection sensitivity of amino acids, peptides, proteins, glycopeptides, glycoproteins and the like fluorescently labeled with the compound of the present invention is extremely high, several picomoles.

【0019】チオール基の蛍光標識化剤としては、他に
7-フルオロ-4-スルファモイル-2,1,3,-ベンゾキサジア
ゾール等の7-ハロ-2,1,3-ベンゾキサジアゾール誘導体
や、2,2'-ジヒドロキシ-6,6'-ジナフチルスルフィド等
のジスルフィド化合物等もあるが、前者はチオール基へ
の特異性の点で問題が残り、また、後者は標識化反応に
時間がかかる点で問題が存する。一方、本発明化合物を
チオール基の蛍光標識化剤として用いた場合にはこれら
の問題は全て解消される。
Other fluorescent labeling agents for thiol groups include
7-halo-2,1,3-benzoxadiazole derivatives such as 7-fluoro-4-sulfamoyl-2,1,3, -benzoxadiazole and 2,2′-dihydroxy-6,6′- Although there are disulfide compounds such as dinaphthyl sulfide, the former has a problem in terms of specificity to a thiol group, and the latter has a problem in that the labeling reaction takes time. On the other hand, when the compound of the present invention is used as a fluorescent labeling agent for a thiol group, all of these problems are solved.

【0020】本発明化合物をチオール基を有する化合物
の水溶性蛍光標識化試薬として用いた場合、一般式(1)
に於いてnが2の化合物がチオール基に結合した際の蛍
光が最も強い。尚、一般式(1)で示される化合物に於い
て、nが0の化合物は、チオール基との反応後に生ずる
蛍光強度が弱く、且つ蛍光検出時の励起波長及び測定波
長が共に短波長側に移行するため共存物質による影響を
受け易くなると言う性質を有しているため、本発明の目
的に用いることは難しい。
When the compound of the present invention is used as a water-soluble fluorescent labeling reagent for a compound having a thiol group, the compound represented by the general formula (1)
In the above, the fluorescence when the compound in which n is 2 binds to the thiol group is the strongest. In the compound represented by the general formula (1), the compound in which n is 0 has low fluorescence intensity generated after the reaction with the thiol group, and both the excitation wavelength and the measurement wavelength at the time of fluorescence detection are on the short wavelength side. It is difficult to use for the purpose of the present invention because it has the property of being easily affected by coexisting substances due to migration.

【0021】以下に実施例を挙げて本発明を更に具体的
に説明するが、本発明はこれら実施例により何ら限定さ
れるものではない。
Hereinafter, the present invention will be described more specifically with reference to examples, but the present invention is not limited to these examples.

【0022】[0022]

【実施例】実施例1.2-ピリジルアミノエチルマレイミ
ド塩酸塩の合成 1)2-(2-アミノエチル)アミノピリジンの合成 2-クロロピリジン85gとエチレンジアミン450gとを、120
℃で8時間撹拌下に反応させた。反応終了後、反応混合
物を減圧濃縮した後、クロロホルムにより目的物を抽出
した。抽出液からクロロホルムを留去し、残渣をベンゼ
ン:石油エーテル(1:5)で再結晶して、淡褐色結晶
の2-(2-アミノエチル)アミノピリジン86gを得た。収率
=83.7%。 融点:36〜40℃。 IRνmax(neat)cm-1:3500〜3100(NH)、3000〜2800(-C
H2-)、780(ピリジン環)。1 H−NMR(60MHz、CDCl3)δppm:1.64(s,2H,NH2)、
2.82〜3.58(m,4H,-CH2CH2-)、6.40〜8.24(m,4H,ピリジ
ン環)。 MS:m/z 137(M+)。 2)N-エトキシカルボニルマレイミドの合成 マレイミド29g、N-メチルモルホリン33ml及び酢酸エチ
ル1300mlを氷冷下、撹拌混合し、これに、氷冷下クロロ
炭酸エチル29mlと酢酸エチル200mlとの混合液を滴下し
た後、更に氷冷下で30分間撹拌、反応させた。反応終了
後、析出物を瀘去し、濾液を減圧濃縮した。残渣を酢酸
エチル:ジエチルエーテル(1:10)から再結晶し、結
晶を瀘取した後、ジエチルエーテルで洗浄して、紫色結
晶のN-エトキシカルボニルマレイミド37gを得た。収率
=79.8%。 融点:57〜59℃。 IRνmax(KBr)cm-1:3100(C-H)、1780(エステル)、171
0(アミド)。1 H−NMR(60MHz、CDCl3)δppm:1.42(t,3H,-C
H3)、4.47(dd,2H,-CH2-)、6.86(s,2H,マレイミド)。 MS:m/z 168(M+)。 3)2-ピリジルアミノエチルマレイミド塩酸塩の合成 上記1で得た2-(2-アミノエチル)アミノピリジン30gを
飽和炭酸水素ナトリウム水溶液1000mlに氷冷下で撹拌、
溶解させた後、これに上記2で得たN-エトキシカルボニ
ルマレイミド37gを加え氷冷下で1時間撹拌、反応させ
た。反応終了後、析出した結晶を濾取し、純水で洗浄し
た後、得られた結晶をジオキサン500mlに懸濁した。こ
れにトリエチルアミン15mlを氷冷下に添加し、1時間撹
拌、反応させた後、室温で更に1時間撹拌、反応させ
た。反応終了後、反応液を減圧濃縮し、得られた残渣か
ら目的物をクロロホルムで抽出した。次いで、抽出液を
再度減圧濃縮し、得られた残渣をジエチルエーテルにて
再結晶した。得られた結晶を3N-塩酸100mlに溶解し、室
温で8時間放置した後、反応液を減圧乾固し、残渣をエ
タノール:メタノール:クロロホルム=20:5:1の混
液260mlに加熱溶解 した。反応液を冷却後、析出した結
晶を濾取して、白色結晶の2-ピリジルアミノエチルマレ
イミド塩酸塩38gを得た。収率=65.5%。 融点:200℃〜(dec.)。 IRνmax(KBr)cm-1:3300〜3000(NH)、1700(イミド)、
1600(アミド)、700(ピリジン環)。1 H−NMR(60MHz、CDCl3):3.55(dd,2H,N-CH2-,J=
5.13)、3.78(t,2H,-CH2-N(CO)2,J=5.13)、6.40〜8.05
(m,6H,ピリジン環 and マレイミド)。 MS:m/z 264(M+)。
EXAMPLES Example 1. Synthesis of 2-pyridylaminoethylmaleimide hydrochloride 1) Synthesis of 2- (2-aminoethyl) aminopyridine 85 g of 2-chloropyridine and 450 g of ethylenediamine were mixed with 120 g of
The reaction was carried out at 0 ° C. for 8 hours with stirring. After completion of the reaction, the reaction mixture was concentrated under reduced pressure, and the desired product was extracted with chloroform. Chloroform was distilled off from the extract, and the residue was recrystallized from benzene: petroleum ether (1: 5) to obtain 86 g of 2- (2-aminoethyl) aminopyridine as pale brown crystals. Yield = 83.7%. Melting point: 36-40C. IRνmax (neat) cm -1 : 3500-3100 (NH), 3000-2800 (-C
H2-), 780 (pyridine ring). 1 H-NMR (60 MHz, CDCl 3 ) δ ppm: 1.64 (s, 2H, NH 2 ),
2.82~3.58 (m, 4H, -CH 2 CH 2 -), 6.40~8.24 (m, 4H, pyridine ring). MS: m / z 137 (M <+> ). 2) Synthesis of N-ethoxycarbonylmaleimide 29 g of maleimide, 33 ml of N-methylmorpholine and 1300 ml of ethyl acetate were stirred and mixed under ice cooling, and a mixture of 29 ml of ethyl chlorocarbonate and 200 ml of ethyl acetate was added dropwise under ice cooling. After that, the mixture was further stirred and reacted under ice cooling for 30 minutes. After the completion of the reaction, the precipitate was filtered off and the filtrate was concentrated under reduced pressure. The residue was recrystallized from ethyl acetate: diethyl ether (1:10), and the crystals were collected by filtration and washed with diethyl ether to obtain purple crystals of N-ethoxycarbonylmaleimide (37 g). Yield = 79.8%. Melting point: 57-59 [deg.] C. IRνmax (KBr) cm -1 : 3100 (CH), 1780 (ester), 171
0 (amide). 1 H-NMR (60 MHz, CDCl 3 ) δ ppm: 1.42 (t, 3H, -C
H 3), 4.47 (dd, 2H, -CH 2 -), 6.86 (s, 2H, maleimide). MS: m / z 168 (M <+> ). 3) Synthesis of 2-pyridylaminoethylmaleimide hydrochloride 30 g of 2- (2-aminoethyl) aminopyridine obtained in 1 above was stirred in 1000 ml of a saturated aqueous solution of sodium hydrogen carbonate under ice-cooling,
After dissolving, 37 g of N-ethoxycarbonylmaleimide obtained in the above 2 was added, and the mixture was stirred and reacted under ice cooling for 1 hour. After completion of the reaction, the precipitated crystals were collected by filtration, washed with pure water, and the obtained crystals were suspended in 500 ml of dioxane. To this, 15 ml of triethylamine was added under ice-cooling, and the mixture was stirred and reacted for 1 hour. Then, the mixture was further stirred and reacted at room temperature for 1 hour. After completion of the reaction, the reaction solution was concentrated under reduced pressure, and the desired product was extracted from the obtained residue with chloroform. Next, the extract was concentrated again under reduced pressure, and the obtained residue was recrystallized from diethyl ether. The obtained crystals were dissolved in 3N-hydrochloric acid (100 ml), allowed to stand at room temperature for 8 hours, the reaction solution was dried under reduced pressure, and the residue was dissolved in 260 ml of a mixed solution of ethanol: methanol: chloroform = 20: 5: 1 by heating. After cooling the reaction solution, the precipitated crystals were collected by filtration to obtain 38 g of 2-pyridylaminoethylmaleimide hydrochloride as white crystals. Yield = 65.5%. Melting point: 200 DEG C .- (dec.). IRνmax (KBr) cm -1 : 3300 to 3000 (NH), 1700 (imide),
1600 (amide), 700 (pyridine ring). 1 H-NMR (60 MHz, CDCl 3 ): 3.55 (dd, 2H, N-CH 2- , J =
5.13), 3.78 (t, 2H , -CH 2 -N (CO) 2, J = 5.13), 6.40~8.05
(m, 6H, pyridine ring and maleimide). MS: m / z 264 (M <+> ).

【0023】実施例2.N-アセチルシステインの蛍光標
識化 (操作法)N-アセチルシステイン1.63gを蒸留水10mlに
溶解したものに、上記実施例1で得た2-ピリジルアミノ
エチルマレイミド塩酸塩2.65gを加え、室温で2時間撹
拌、反応させた後、反応液10μlを高速液体クロマトグ
ラフィ(HPLC)により分析した。尚、HPLCの測
定条件は以下の通り。 ・装置:SHIMADSU LC-6A((株)島津製作所製)。 ・カラム:Wakopak 5C18 (4.6 x 150 mm) (和光純薬
工業(株)製)。 ・溶離液A:0.1M 酢酸アンモニウム緩衝液 (pH 4.0)。 ・溶離液B:50% アセトニトリルを含む0.1M 酢酸アン
モニウム緩衝液 (pH 4.0)。 ・グラジエント:A→B 0→15分 (リニア
グラジエント) ・溶離液流速:1.5ml/min。 ・カラム温度:55℃。 ・蛍光検出波長:励起波長320nm及び蛍光波長400nm。 (結果)HPLCによる分析結果を図1に示す。尚、図
中、1はN-アセチルシステインと2-ピリジルアミノエチ
ルマレイミド塩酸塩とを反応させた溶液を試料として得
られたHPLCによる分析結果を、2は2-ピリジルアミ
ノエチルマレイミド塩酸塩のみを含む蒸留水を試料とし
て得られたHPLCによる分析結果を夫々示す。図1か
ら明らかな如く、2-ピリジルアミノエチルマレイミドそ
のものは9.22分に溶出し極めて弱いピークを形成する
が、N-アセチルシステインと反応させることにより9.22
分のピークは消失し、その代りに8.89分に新たな蛍光ピ
ークが出現することが判る。この結果から、本発明化合
物は、速やかに且つ高い反応率でチオール基と反応し、
得られた反応生成物は強い蛍光を発することが判る。
Embodiment 2 FIG. Fluorescent labeling of N-acetylcysteine (Operation method) To a solution of 1.63 g of N-acetylcysteine in 10 ml of distilled water, 2.65 g of 2-pyridylaminoethylmaleimide hydrochloride obtained in Example 1 above was added, and the mixture was added at room temperature. After stirring and reacting for 10 hours, 10 μl of the reaction solution was analyzed by high performance liquid chromatography (HPLC). The HPLC measurement conditions are as follows. -Equipment: SHIMADSU LC-6A (manufactured by Shimadzu Corporation). -Column: Wakopak 5C18 (4.6 x 150 mm) (manufactured by Wako Pure Chemical Industries, Ltd.). -Eluent A: 0.1 M ammonium acetate buffer (pH 4.0). Eluent B: 0.1 M ammonium acetate buffer (pH 4.0) containing 50% acetonitrile.・ Gradient: A → B 0 → 15 minutes (linear gradient) ・ Eluent flow rate: 1.5 ml / min. -Column temperature: 55 ° C. -Fluorescence detection wavelength: excitation wavelength 320nm and fluorescence wavelength 400nm. (Results) The analysis results by HPLC are shown in FIG. In the figures, 1 is the analysis result by HPLC obtained by using a solution obtained by reacting N-acetylcysteine and 2-pyridylaminoethylmaleimide hydrochloride as a sample, and 2 is the distillation result containing only 2-pyridylaminoethylmaleimide hydrochloride. The analysis results by HPLC obtained using water as a sample are shown respectively. As is clear from FIG. 1, 2-pyridylaminoethylmaleimide itself elutes at 9.22 minutes and forms an extremely weak peak.
It can be seen that the minute peak disappears and a new fluorescent peak appears at 8.89 minutes instead. From this result, the compound of the present invention reacted with the thiol group promptly and at a high conversion,
It can be seen that the obtained reaction product emits strong fluorescence.

【0024】実施例3.グルタチオンの蛍光標識化及び
その定量 (蛍光標識化試液)上記実施例1で得られた2-ピリジル
アミノエチルマレイミド塩酸塩を蒸留水に溶解して0.1M
溶液としたものを、蛍光標識化試液とした。 (反応緩衝液)リン酸二水素ナトリウム・2水和物15.6
gを90mlの蒸留水に溶解したものを、1N水酸化ナトリウ
ム溶液でpHを7.0に調整した後、全量を100mlとしたも
のを反応緩衝液とした。 (試料)グルタチオン(和光純薬工業(株)製)を蒸留
水に適宜溶解して 1、5、10、50、100又は200μg/ml
の溶液を調製し、試料とした。 (操作法)蛍光標識化試薬20μl、反応緩衝液60μl及び
所定濃度の試料20μlを混合し、37℃で3時間反応させ
た。反応終了後、反応液10μlをとり、これに蒸留水200
μlを加えてよく混和し、その100μlをHPLCにより
分析した。尚、HPLCの測定条件は以下の通り。 ・装置:SHIMADSU LC-6A((株)島津製作所製)。 ・カラム:Wakopak 5C18 (4.6 x 150 mm、和光純薬工業
(株)製)。 ・溶離液A:0.1M 酢酸アンモニウム緩衝液(pH 4.0)。 ・溶離液B:60% アセトニトリルを含む0.1M 酢酸アン
モニウム緩衝液(pH 4.0)。 ・グラジエント:A 0→ 5分 A→B 5→20分 (リニアグラジエント) B 20→25分 ・溶離液流速:1.5ml/min。 ・カラム温度:55℃。 ・蛍光検出波長:励起波長 314nm及び蛍光波長 386nm。 (結果)グルタチオン濃度と蛍光標識化グルタチオンの
蛍光強度との関係を示すグラフを図2に示す(尚、HP
LCによる分析の結果、2-ピリジルアミノエチルマレイ
ミドとグルタチオンとの反応生成物は、17.6分に溶出す
ることが判った。)。図2より、試料中のグルタチオン
濃度と、該試料を用いて得られる蛍光標識化グルタチオ
ンの蛍光強度との関係を示すグラフは良好な直線性を示
すことが判る。以上の結果から、本発明化合物はグルタ
チオンと定量的に反応すること、及び本発明化合物を蛍
光標識化試薬として用いてグルタチオンを蛍光標識化す
ることにより、試料中のグルタチオン量を高感度で定量
できることが判った。
Embodiment 3 FIG. Fluorescence labeling of glutathione and its quantification (Fluorescent labeling reagent solution) The 2-pyridylaminoethylmaleimide hydrochloride obtained in Example 1 was dissolved in distilled water to give 0.1 M
The solution was used as a fluorescent labeling reagent. (Reaction buffer) Sodium dihydrogen phosphate dihydrate 15.6
g was dissolved in 90 ml of distilled water, the pH was adjusted to 7.0 with a 1N sodium hydroxide solution, and the total volume was adjusted to 100 ml, which was used as a reaction buffer. (Sample) Glutathione (manufactured by Wako Pure Chemical Industries, Ltd.) is appropriately dissolved in distilled water, and 1, 5, 10, 50, 100 or 200 μg / ml
Was prepared and used as a sample. (Operation method) 20 µl of a fluorescent labeling reagent, 60 µl of a reaction buffer, and 20 µl of a sample having a predetermined concentration were mixed and reacted at 37 ° C for 3 hours. After the reaction is completed, take 10 μl of the reaction solution, add 200 ml of distilled water
μl was added and mixed well, and 100 μl thereof was analyzed by HPLC. The HPLC measurement conditions are as follows. -Equipment: SHIMADSU LC-6A (manufactured by Shimadzu Corporation).・ Column: Wakopak 5C18 (4.6 x 150 mm, Wako Pure Chemical Industries)
Co., Ltd.). Eluent A: 0.1 M ammonium acetate buffer (pH 4.0). Eluent B: 0.1 M ammonium acetate buffer (pH 4.0) containing 60% acetonitrile.・ Gradient: A 0 → 5 minutes A → B 5 → 20 minutes (linear gradient) B 20 → 25 minutes ・ Eluent flow rate: 1.5 ml / min. -Column temperature: 55 ° C. -Fluorescence detection wavelength: excitation wavelength 314 nm and fluorescence wavelength 386 nm. (Results) FIG. 2 is a graph showing the relationship between the glutathione concentration and the fluorescence intensity of the fluorescence-labeled glutathione.
As a result of analysis by LC, it was found that the reaction product of 2-pyridylaminoethylmaleimide and glutathione eluted at 17.6 minutes. ). FIG. 2 shows that the graph showing the relationship between the glutathione concentration in the sample and the fluorescence intensity of the fluorescence-labeled glutathione obtained using the sample shows good linearity. From the above results, it can be seen that the compound of the present invention reacts quantitatively with glutathione and that the amount of glutathione in a sample can be quantified with high sensitivity by fluorescently labeling glutathione using the compound of the present invention as a fluorescent labeling reagent. I understood.

【発明の効果】以上述べた如く、本発明は、微量物質の
蛍光標識化に極めて有効なピリジルアミノ基を、水溶媒
等中に於いてチオール基を有する化合物に容易に導入し
得る水溶性蛍光標識化試薬と、これを用いたチオール基
を有する化合物へのピリジルアミノ基の導入方法を提供
するものであり、本発明によれば、従来の方法では抗
体、酵素、ホルモン、各種因子類、ハプテン等の生理活
性物質にこれらの活性を保持させたまま導入するのが難
しかったピリジルアミノ基を、穏和な条件下でこれらの
活性を保持させたまま導入することが可能となる点に優
れた効果を奏するものであり、斯業に貢献するところ大
なる発明である。
As described above, the present invention provides a water-soluble fluorescent label which can easily introduce a pyridylamino group, which is extremely effective for fluorescent labeling of a trace substance, into a compound having a thiol group in an aqueous solvent or the like. The present invention provides a method for introducing a pyridylamino group into a compound having a thiol group using the same, and according to the present invention, antibodies, enzymes, hormones, various factors, haptens, etc. It has an excellent effect in that it is possible to introduce a pyridylamino group, which was difficult to introduce into a physiologically active substance while retaining these activities, while allowing these activities to be retained under mild conditions. It is a great invention that contributes to the industry.

【図面の簡単な説明】[Brief description of the drawings]

【図1】実施例2で得られた、本発明化合物により蛍光
標識化されたN-アセチルシステインの高速液体クロマト
グラフィ(HPLC)による分析結果を示す。
FIG. 1 shows the results of high-performance liquid chromatography (HPLC) analysis of N-acetylcysteine fluorescently labeled with the compound of the present invention, obtained in Example 2.

【図2】実施例3で得られた、本発明化合物により蛍光
標識化されたグルタチオンの濃度(μg/ml)と蛍光強度
(10-3μV)との関係を示すグラフである。
FIG. 2 is a graph showing the relationship between the concentration (μg / ml) of glutathione fluorescently labeled with the compound of the present invention and the fluorescence intensity (10-3 μV) obtained in Example 3.

【符号の説明】[Explanation of symbols]

図1に於ける各符号は夫々以下のものを示す。 1 N-アセチルシステインと2-ピリジルアミノエチルマ
レイミド塩酸塩とを反応させた溶液を試料として得られ
たHPLCによる分析結果。 2 2-ピリジルアミノエチルマレイミド塩酸塩のみを含
む蒸留水を試料として得られたHPLCによる分析結
果。
Each symbol in FIG. 1 indicates the following. Analysis results by HPLC obtained using a solution obtained by reacting 1 N-acetylcysteine with 2-pyridylaminoethylmaleimide hydrochloride as a sample. 2 Analysis results by HPLC obtained using distilled water containing only 2-pyridylaminoethylmaleimide hydrochloride as a sample.

───────────────────────────────────────────────────── フロントページの続き 審査官 冨永 保 (58)調査した分野(Int.Cl.7,DB名) C07D 401/12 C09K 11/06 G01N 33/533 CA(STN) REGISTRY(STN)────────────────────────────────────────────────── ─── Continuing from the front page Examiner Tamotsu Tominaga (58) Field surveyed (Int. Cl. 7 , DB name) C07D 401/12 C09K 11/06 G01N 33/533 CA (STN) REGISTRY (STN)

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】下記一般式(1) 【化1】 (式中、R1は2-ピリジルアミノ基又は3-ピリジルアミ
ノ基を表わし、nは1〜4の整数を表わす。)で示され
る化合物又はその塩。
(1) The following general formula (1): (Wherein, R 1 represents a 2-pyridylamino group or a 3-pyridylamino group, and n represents an integer of 1 to 4) or a salt thereof.
【請求項2】下記一般式(1) 【化2】 (式中、R1、及びnは前記に同じ。)で表わされる化
合物又はその塩と、チオール基を有する化合物とを水又
は極性有機溶媒、或はこれらの混合溶媒中で反応させる
ことを特徴とする、チオール基を有する化合物の蛍光標
識化方法。
(2) The following general formula (1): Wherein R 1 and n are as defined above, or a salt thereof, and a compound having a thiol group in water or a polar organic solvent, or a mixed solvent thereof. Fluorescent labeling of a compound having a thiol group.
【請求項3】チオール基を有する化合物が、アミノ酸、
ペプチド、蛋白質、糖ペプチド又は糖蛋白質である、請
求項2に記載の蛍光標識化方法。
3. The compound having a thiol group is an amino acid,
3. The fluorescent labeling method according to claim 2, which is a peptide, protein, glycopeptide or glycoprotein.
JP4081564A 1992-03-03 1992-03-03 Novel maleimide derivative and fluorescent labeling method of compound having thiol group using the same Expired - Lifetime JP3057887B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4081564A JP3057887B2 (en) 1992-03-03 1992-03-03 Novel maleimide derivative and fluorescent labeling method of compound having thiol group using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4081564A JP3057887B2 (en) 1992-03-03 1992-03-03 Novel maleimide derivative and fluorescent labeling method of compound having thiol group using the same

Publications (2)

Publication Number Publication Date
JPH06122679A JPH06122679A (en) 1994-05-06
JP3057887B2 true JP3057887B2 (en) 2000-07-04

Family

ID=13749792

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4081564A Expired - Lifetime JP3057887B2 (en) 1992-03-03 1992-03-03 Novel maleimide derivative and fluorescent labeling method of compound having thiol group using the same

Country Status (1)

Country Link
JP (1) JP3057887B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033884A1 (en) * 1996-03-15 1997-09-18 Ss Pharmaceutical Co., Ltd. Reagents for labeling sh groups, process for the preparation of them, and method for labeling with them
US7897787B2 (en) * 2005-09-13 2011-03-01 The University Of Tokyo Maleimide derivative
JP4869871B2 (en) * 2006-11-01 2012-02-08 三菱電機株式会社 Mercapto group-containing substance detection apparatus and method
JP2010071986A (en) * 2008-08-20 2010-04-02 Kazuhiro Imai Fluorescence reagent

Also Published As

Publication number Publication date
JPH06122679A (en) 1994-05-06

Similar Documents

Publication Publication Date Title
JP7000489B2 (en) Haptens, hapten conjugates, their compositions and methods of their manufacture and use
Elia Biotinylation reagents for the study of cell surface proteins
Song et al. Practical synthesis of maleimides and coumarin-linked probes for protein and antibody labelling via reduction of native disulfides
EP0635006B1 (en) Europium and terbium chelators for time-resolved fluorometric assays
US7595198B2 (en) Photocleavable isotope-coded affinity tags
JP2627503B2 (en) New peptide derivatives
JPS60252684A (en) Fluorescent assembly
EP0626068A1 (en) Luminescent lanthanide chelates
JPH08259600A (en) Polypeptide and derivative of protein
CA1152490A (en) Beta-galactosyl-umbelliferone-labeled protein and polypeptide conjugates
CN101750486A (en) Method for labeling antibody by fluorophore generated by combination of iridium coordination compound and histidine
US5324835A (en) Pyridazinoquinoxalinones for use as chemiluminescent agents
US20210395606A1 (en) Chromophoric structures for macrocyclic lanthanide chelates
JP3057887B2 (en) Novel maleimide derivative and fluorescent labeling method of compound having thiol group using the same
CA1134830A (en) Polyfunctional disulfide compound
JPS6127710B2 (en)
AU637327B2 (en) Protein derivatives and a process for their preparation
CN106831634A (en) A kind of Ratiometric fluorescent probe for detecting AAP and preparation method and application
Féau et al. Synthesis of a coumarin-based europium complex for bioanalyte labeling
WO2015029050A1 (en) A squaraine based fluorescent probe and a process for the preparation thereof
JP2010502573A (en) Luminescent compound and conjugate containing double sensitizer and use thereof
AU637326B2 (en) Protein derivatives and a process for their preparation
JP2007315779A (en) Diagnostic drug and diagnostic method using the same
CN105503879A (en) Method for immobilizing proteins
US11614445B2 (en) Background blockers for binding assays

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20000321